Stemedica Cell Technologies, Inc. (SCT) is a privately held specialty bio-pharmaceutical company which is engaged in developing and producing adult stem cells. The adult stem cells offered by the company are used by approved research institutions and hospitals for pre-clinical and clinical studies. The company develops regulatory pathways for traumatic brain injury and wound repair in the US. In addition, SCT offers adult stem cells to hospitals and research centers which conducts studies under the protocols approved by the appropriate regulatory agencies. It has operations in Mexico, Russia, Korea and Switzerland. The company has developed various strategic collaborations with leading physicians, scientists, and organizations. SCT is headquartered at San Diego in California, the US.